Literature DB >> 21951284

Spontaneous and induced osteoclastogenic behaviour of human peripheral blood mononuclear cells and their CD14(+) and CD14(-) cell fractions.

J Costa-Rodrigues1, A Fernandes, M H Fernandes.   

Abstract

OBJECTIVES: Osteoclasts are descended from the CD14(+) monocyte/macrophage lineage, but influence of other haematopoietic cells on osteoclastic commitment of their precursors has remained poorly understood. In this study, osteoclastogenic behaviour of peripheral blood mononuclear cells (PBMC) and their CD14(+) and CD14(-) subpopulations has been accessed, in the absence or presence of M-CSF and RANKL.
MATERIALS AND METHODS: Cell cultures were characterized for presence of actin rings and vitronectin and calcitonin receptors, TRAP activity and calcium phosphate resorbing activity, expression of osteoclast-related genes and secretion of M-CSF and RANKL.
RESULTS: In the absence of growth factors, PBMC and CD14(+) cultures had some degree of cell survival, and some spontaneous osteoclastogenesis was observed, only on cultures of the former. Supplementation with M-CSF and RANKL significantly increased osteoclastogenic behaviour of cell cultures, particularly CD14(+) cell cultures. Nevertheless, PBMC derived a higher degree of osteoclastogenesis, either as absolute values or after normalization by protein content. It was observed that unlike CD14(+) cells, PBMC were able to express M-CSF and RANKL, which increased following growth factor treatment. Also, expression of TNF-α, GM-CSF, IL-1β, IL-6 and IL-17 was higher in PBMC cultures. Finally, CD14(-) cultures exhibited limited cell survival and did not reveal any osteoclast features.
CONCLUSIONS: Results show that although osteoclastic precursors reside in the CD14(+) cell subpopulation, other populations (such as CD14(-) cells) derived from PBMC, have the ability to modulate osteoclastogenesis positively.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21951284      PMCID: PMC6495674          DOI: 10.1111/j.1365-2184.2011.00768.x

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  45 in total

Review 1.  T-cell involvement in osteoclast biology: implications for rheumatoid bone erosion.

Authors:  D O'Gradaigh; J E Compston
Journal:  Rheumatology (Oxford)       Date:  2003-07-16       Impact factor: 7.580

2.  Characterisation of the osteoclastogenic potential of human osteoblastic and fibroblastic conditioned media.

Authors:  João Costa-Rodrigues; Cristina A Teixeira; Paula Sampaio; Maria H Fernandes
Journal:  J Cell Biochem       Date:  2010-01-01       Impact factor: 4.429

3.  Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells.

Authors:  N Udagawa; N Takahashi; T Akatsu; H Tanaka; T Sasaki; T Nishihara; T Koga; T J Martin; T Suda
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

4.  Increased expression of interleukin 17 in inflammatory bowel disease.

Authors:  S Fujino; A Andoh; S Bamba; A Ogawa; K Hata; Y Araki; T Bamba; Y Fujiyama
Journal:  Gut       Date:  2003-01       Impact factor: 23.059

5.  Identification and characterization of a novel monocyte subpopulation in human peripheral blood.

Authors:  B Passlick; D Flieger; H W Ziegler-Heitbrock
Journal:  Blood       Date:  1989-11-15       Impact factor: 22.113

6.  Paracrine-mediated differentiation and activation of human haematopoietic osteoclast precursor cells by skin and gingival fibroblasts.

Authors:  J Costa-Rodrigues; M H Fernandes
Journal:  Cell Prolif       Date:  2011-06       Impact factor: 6.831

7.  Endothelial-like cells derived from human CD14 positive monocytes.

Authors:  B Fernandez Pujol; F C Lucibello; U M Gehling; K Lindemann; N Weidner; M L Zuzarte; J Adamkiewicz; H P Elsässer; R Müller; K Havemann
Journal:  Differentiation       Date:  2000-05       Impact factor: 3.880

8.  Osteoclast markers accumulate on cells developing from human peripheral blood mononuclear precursors.

Authors:  J Faust; D L Lacey; P Hunt; T L Burgess; S Scully; G Van; A Eli; Y Qian; V Shalhoub
Journal:  J Cell Biochem       Date:  1999-01-01       Impact factor: 4.429

9.  Blood monocytes consist of two principal subsets with distinct migratory properties.

Authors:  Frederic Geissmann; Steffen Jung; Dan R Littman
Journal:  Immunity       Date:  2003-07       Impact factor: 31.745

10.  Interleukin-6, interleukin-8 and monocyte chemotactic peptide-1 gene expression and protein synthesis are independently modulated by hemodialysis membranes.

Authors:  G Pertosa; G Grandaliano; L Gesualdo; E Ranieri; R Monno; F P Schena
Journal:  Kidney Int       Date:  1998-08       Impact factor: 10.612

View more
  12 in total

1.  Simulating In Vitro the Bone Healing Potential of a Degradable and Tailored Multifunctional Mg-Based Alloy Platform.

Authors:  Victor Martin; Mónica Garcia; Maria de Fátima Montemor; João Carlos Salvador Fernandes; Pedro Sousa Gomes; Maria Helena Fernandes
Journal:  Bioengineering (Basel)       Date:  2022-06-15

2.  Behaviour of co-cultured human osteoclastic and osteoblastic cells exposed to endodontic sealers' extracts.

Authors:  Cláudia Rodrigues; João Costa-Rodrigues; José A Capelas; Maria H Fernandes
Journal:  Clin Oral Investig       Date:  2013-04-20       Impact factor: 3.573

3.  Inhibition of human in vitro osteoclastogenesis by Equisetum arvense.

Authors:  J Costa-Rodrigues; S C Carmo; J C Silva; M H R Fernandes
Journal:  Cell Prolif       Date:  2012-12       Impact factor: 6.831

4.  Ankylosing Spondylitis Patients Have Impaired Osteoclast Gene Expression in Circulating Osteoclast Precursors.

Authors:  Inês P Perpétuo; Joana Caetano-Lopes; Elsa Vieira-Sousa; Raquel Campanilho-Marques; Cristina Ponte; Helena Canhão; Mari Ainola; João E Fonseca
Journal:  Front Med (Lausanne)       Date:  2017-01-27

5.  Methotrexate and low-dose prednisolone downregulate osteoclast function by decreasing receptor activator of nuclear factor-κβ expression in monocytes from patients with early rheumatoid arthritis.

Authors:  Inês Pedro Perpétuo; Joana Caetano-Lopes; Ana Maria Rodrigues; Raquel Campanilho-Marques; Cristina Ponte; Helena Canhão; Mari Ainola; João Eurico Fonseca
Journal:  RMD Open       Date:  2017-07-13

6.  Effect of Tumor Necrosis Factor Inhibitor Therapy on Osteoclasts Precursors in Rheumatoid Arthritis.

Authors:  Inês P Perpétuo; Joana Caetano-Lopes; Ana Maria Rodrigues; Raquel Campanilho-Marques; Cristina Ponte; Helena Canhão; Mari Ainola; João E Fonseca
Journal:  Biomed Res Int       Date:  2017-02-13       Impact factor: 3.411

Review 7.  The multi-differentiation potential of peripheral blood mononuclear cells.

Authors:  Min Zhang; Bing Huang
Journal:  Stem Cell Res Ther       Date:  2012-11-30       Impact factor: 6.832

8.  Bone Anabolic Effects of Soluble Si: In Vitro Studies with Human Mesenchymal Stem Cells and CD14+ Osteoclast Precursors.

Authors:  J Costa-Rodrigues; S Reis; A Castro; M H Fernandes
Journal:  Stem Cells Int       Date:  2015-12-20       Impact factor: 5.443

9.  Craniometaphyseal Dysplasia Mutations in ANKH Negatively Affect Human Induced Pluripotent Stem Cell Differentiation into Osteoclasts.

Authors:  I-Ping Chen; Raj Luxmi; Jitendra Kanaujiya; Zhifang Hao; Ernst J Reichenberger
Journal:  Stem Cell Reports       Date:  2017-10-19       Impact factor: 7.765

10.  Gap junctional communication is involved in differentiation of osteoclasts from bone marrow and peripheral blood monocytes.

Authors:  Elina Kylmäoja; Miho Nakamura; Hanna Kokkonen-Puuperä; Veli-Pekka Ronkainen; Petri Lehenkari; Juha Tuukkanen
Journal:  Heliyon       Date:  2018-05-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.